Marino Garcia
CEO, President at Dianthus Therapeutics, Inc. /DE/ (DNTH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $28.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 7SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 10,384220,908 held (−4%) | $107.49 | $1.1M | -23.4% |
| Aug 7SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 23,907197,001 held (−11%) | $108.05 | $2.6M | -23.8% |
| Aug 7SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 2,373194,628 held (−1%) | $109.10 | $259K | -24.5% |
| Aug 7SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 2,536192,092 held (−1%) | $110.02 | $279K | -25.1% |
| Aug 7SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 800191,292 held (−0%) | $110.76 | $89K | -25.6% |
| Aug 7SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 104,09187,102 held (−54%) | $107.96 | $11.2M | -23.7% |
| Aug 7SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 21,90965,292 held (−25%) | $108.72 | $2.4M | -24.2% |
| Mar 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 43,50579,413 held (−35%) | $80.69 | $3.5M | +2.1% |
| Mar 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 65,51713,896 held (−83%) | $81.74 | $5.4M | +0.8% |
| Mar 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 12,7961,100 held (−92%) | $82.60 | $1.1M | -0.3% |
| Mar 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 200900 held (−18%) | $83.38 | $17K | -1.2% |
| Mar 13SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 900 | $85.53 | $77K | -3.7% |
- Sell
CEO, President Marino Garcia sold $1.1M of DNTH at $107.49 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marino Garcia sold $2.6M of DNTH at $108.05 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marino Garcia sold $259K of DNTH at $109.10 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marino Garcia sold $279K of DNTH at $110.02 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marino Garcia sold $89K of DNTH at $110.76 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Marino Garcia sold $11.2M of DNTH at $107.96 — cuts the stake by 54%; pre-scheduled 10b5-1 plan sale.